31 related articles for article (PubMed ID: 38723189)
1. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Lobo R; Soerdal T; Ekerhovd E; Cohlen B; Porcu E; Schenk M; Shufaro Y; Smeenk J; Suerdieck MB; Pinton P; Pinborg A;
Hum Reprod; 2024 May; ():. PubMed ID: 38723189
[TBL] [Abstract][Full Text] [Related]
2. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
[TBL] [Abstract][Full Text] [Related]
3. Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial.
Colombo C; Pistoljevic-Kristiansen N; Saupstad M; Bergenheim SJ; Spangmose AL; Klajnbard A; la Cour Freiesleben N; Løkkegaard EC; Englund AL; Husth M; Breth Knudsen U; Alsbjerg B; Prætorius L; Løssl K; Schmidt L; Pinborg A
Hum Reprod; 2023 Oct; 38(10):1970-1980. PubMed ID: 37634089
[TBL] [Abstract][Full Text] [Related]
4. Double versus single stimulation in young low prognosis patients followed by a fresh embryo transfer: a randomized controlled trial (DUOSTIM-fresh).
Racca A; Rodriguez I; Garcia S; Arroyo G; Polyzos NP
Hum Reprod; 2024 Jun; ():. PubMed ID: 38845190
[TBL] [Abstract][Full Text] [Related]
5. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3).
Donnez J; Becker C; Taylor H; Carmona Herrera F; Donnez O; Horne A; Paszkowski M; Petraglia F; Renner SP; Patel A; Boolell M; Bestel E; Dolmans MM
Hum Reprod; 2024 Jun; 39(6):1208-1221. PubMed ID: 38648863
[TBL] [Abstract][Full Text] [Related]
6. No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.
Katalinic A; Noftz MR; Garcia-Velasco JA; Shulman LP; van den Anker JN; Strauss Iii JF
Hum Reprod Open; 2024; 2024(1):hoae004. PubMed ID: 38344249
[TBL] [Abstract][Full Text] [Related]
7. Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
Kamphuis D; van Eekelen R; van Welie N; Dreyer K; van Rijswijk J; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; van Baal WM; Traas MAF; van Peperstraten AM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; Lambeek AF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Tros R; Lambalk CB; Stoker J; van Wely M; Bossuyt PMM; Mol BWJ; Mijatovic V
Hum Reprod; 2024 Jun; 39(6):1222-1230. PubMed ID: 38600625
[TBL] [Abstract][Full Text] [Related]
8. Individualized dosing of follitropin delta affects live birth and safety in in vitro fertilization treatment: an individual participant data meta-analysis of randomized controlled trials.
Nelson SM; Shaw M; Alrashid K; Anderson RA
Fertil Steril; 2024 May; ():. PubMed ID: 38750874
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis.
Palomba S; Caserta D; Levi-Setti PE; Busnelli A
J Ovarian Res; 2024 Mar; 17(1):60. PubMed ID: 38486276
[TBL] [Abstract][Full Text] [Related]
10. Effect of prematurely elevated late follicular progesterone on pregnancy outcomes following ovarian stimulation-intrauterine insemination for unexplained infertility: secondary analysis of the AMIGOS trial.
Burks HR; Peck JD; Gavrizi S; Anderson ZS; Diamond MP; Hansen KR
Hum Reprod; 2024 May; ():. PubMed ID: 38822675
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of ovarian stimulation with follitropin delta in a mixed regimen with HP-hMG: a real-world retrospective analysise.
Lim LJ; Kit AMF; Wong PS
Med J Malaysia; 2024 May; 79(3):275-280. PubMed ID: 38817059
[TBL] [Abstract][Full Text] [Related]
12. GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes.
Hill MJ; Chason RJ; Payson MD; Segars JH; Csokmay JM
Reprod Biomed Online; 2012 Sep; 25(3):284-91. PubMed ID: 22796230
[TBL] [Abstract][Full Text] [Related]
13. No pain relief by virtual reality during hysterosalpingography (HSG): results from a randomized controlled trial.
Rosielle K; van Haaps AP; Kuijper EAM; Tonch N; Karim DENB; Oskam MA; van den IJssel R; Mol BWJ; Lambalk CB; Dreyer K; Mijatovic V
Hum Reprod; 2024 Jun; ():. PubMed ID: 38863305
[TBL] [Abstract][Full Text] [Related]
14. Circulating anti-Müllerian hormone levels in pre-menopausal women: novel genetic insights from a genome-wide association meta-analysis.
Pujol-Gualdo N; Karjalainen MK; Võsa U; Arffman RK; Mägi R; Ronkainen J; Laisk T; Piltonen TT
Hum Reprod; 2024 May; ():. PubMed ID: 38815977
[TBL] [Abstract][Full Text] [Related]
15. Eggsurance? A randomized controlled trial of a decision aid for elective egg freezing.
Sandhu S; Hickey M; Koye DN; Braat S; Lew R; Hart R; Norman RJ; Hammarberg K; Anderson RA; Peate M;
Hum Reprod; 2024 Jun; ():. PubMed ID: 38876980
[TBL] [Abstract][Full Text] [Related]
16. The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.
Drechsel KCE; Broer SL; Stoutjesdijk FS; van Dulmen-den Broeder E; Beishuizen A; Wallace WH; Körholz D; Mauz-Körholz C; Hasenclever D; Cepelova M; Uyttebroeck A; Ronceray L; Twisk JWR; Kaspers GJL; Veening MA
Hum Reprod; 2024 May; ():. PubMed ID: 38794915
[TBL] [Abstract][Full Text] [Related]
17. Protocol change improves live birth and recurrent cycle cancellation rates after a previous IVF cycle cancellation: an analysis of 13 000 autologous cycles reported to SART CORS.
Kahn JL; Wu H; Gerber R; Shah T; Lieman H; Pollack SE; Singh M; Jindal S
Hum Reprod; 2024 May; ():. PubMed ID: 38783613
[TBL] [Abstract][Full Text] [Related]
18. The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials.
Doroftei B; Ilie OD; Dabuleanu AM; Armeanu T; Maftei R
J Assist Reprod Genet; 2024 May; ():. PubMed ID: 38809330
[TBL] [Abstract][Full Text] [Related]
19. Comparison of HCG Trigger versus Dual Trigger in Improving Pregnancy Outcomes in Patients with Different Ovarian Responses: A Retrospective Study.
Xu K; Wang J; Yang S; Wang Z; Hou N; Sun M
Int J Endocrinol; 2024; 2024():2507026. PubMed ID: 38855192
[TBL] [Abstract][Full Text] [Related]
20. Comparison of stimulation protocols for dose determination of gonadotropins: A systematic review and Bayesian network meta-analysis based on randomized controlled trials.
Peng Y; Ma S; Hu L; Li Y; Wang X; Xiong Y; Tan J; Gong F
Int J Gynaecol Obstet; 2024 May; ():. PubMed ID: 38779824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
